[an error occurred while processing this directive]

Advanced Ultrasound in Diagnosis and Therapy ›› 2023, Vol. 7 ›› Issue (1): 38-41.doi: 10.37015/AUDT.2023.210040

• • 上一篇    下一篇

  

  • 收稿日期:2021-12-08 接受日期:2022-01-07 出版日期:2023-03-30 发布日期:2023-03-30

Sarcomatoid Intrahepatic Cholangiocarcinoma: A Case Report

Cuiwei Wang, MD, Xin-Hua Ye, MD()   

  1. Department of Ultrasound, The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
  • Received:2021-12-08 Accepted:2022-01-07 Online:2023-03-30 Published:2023-03-30
  • Contact: Xin-Hua Ye, MD E-mail:Ultrasonoye@163.com

RichHTML

5

PDF (PC)

571

Abstract:

Conventional two-dimensional ultrasonography revealed a hypoechoic mass in the liver of a middle-aged male patient. Enhanced ultrasound suggested intrahepatic cholangiocarcinoma. Enhanced MRI confirmed it as liver cancer. The patient underwent partial liver resection and was pathologically diagnosed as sarcomatoid intrahepatic cholangiocarcinoma. Pulmonary infection occurred one month after surgery. Chest CT suggested left rib metastasis and then radiotherapy was performed. The patient was treated with Lenvatinib after discharge. No recurrence was observed within 36 months. He survived much longer than other patients reported in the literature. The survival of patients with intrahepatic cholangiocarcinoma can be prolonged through early detection and treatments of surgery, radiotherapy and targeted therapy.

Key words: Sarcomatoid intrahepatic cholangiocarcinoma, Contrast-enhanced ultrasonography, Ultrasound

"

"

"

"

[1] Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. WHO Classification of tumours editorial board. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76:182-188.
doi: 10.1111/his.13975 pmid: 31433515
[2] Huang YZ, Yang XE, Yang JH. Progress in the treatment of intrahepatic cholangiocarcinoma. Journal of Hepatobiliary Surgery 2014; 022:73-76.
[3] Malhotra S, Wood J, Mansy T, Singh R, Zaitoun A, Madhusudan S. Intrahepatic sarcomatoid cholangiocarcinoma. J Oncol 2010; 2010:701476.
[4] Inoue Y, Lefor AT, Yasuda Y. Intrahepatic cholangiocarcinoma with sarcomatous changes. Case Rep Gastroenterol 2012; 6:1-4.
doi: 10.1159/000335883 pmid: 22379464
[5] Kaibori M, Kawaguchi Y, Yokoigawa N, Yanagida H, Takai S, Kwon AH, et al. Intrahepatic sarcomatoid cholangiocarcinoma. J Gastroenterol 2003; 38:1097-1101.
doi: 10.1007/s00535-003-1203-y pmid: 14673730
[6] Jang KS, Jang SH, Oh YH, et al. Sarcomatoid carcinoma of the distal common bile duct: a case report. Korean J Path01 2005; 39: 360-363.
[7] Xu YY, Xie DH. Imaging findings and clinical pathological features of primary hepatic sarcomatoid carcinoma. Journal of Practical Radiology 2019; 35:1698-1701.
[8] Zhang SH, Chen Y, Wang Y, NI CR, MH Zhu. ClinicopathoIogic featllres of sarcomatoid intrahepatic cholangiocarcinoma: a report of 16 cases. Chinese Journal of Diagnostic Pathology 2012; 19:161-164.
[9] Kim DG, Park SY, Kim H, Chun YH, Moon WS, Park SH. A comprehensive karyotypic analysis ona newly established sarcomatoid hepatocellularcarcinoma cell line SH-J1 by comparative genomichybridization and chromosome painting. Cancer Genet Cytogenet 2002; 132:120-124.
doi: 10.1016/S0165-4608(01)00543-X
[10] Mehmet B, Huseyin T, Sennur B, Mustafa K, Cem B. CT and MRI findings of sarcomatoid cholangiocarcinoma. Cancer Imaging 2012; 12:447-451.
doi: 10.1102/1470-7330.2012.0036 pmid: 23092855
No related articles found!
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
[an error occurred while processing this directive]